FDA recall, , Moderate risk
New York Blood Center Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were collected from a donor previously deferred for hepatitis C antibody testing.
Recall ended Aug 13, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
New York Blood Center Inc began a recall of Red Blood Cells, Leukocytes Reduced on July 16, 2026, because the product was collected from a donor who was previously deferred for testing repeatedly reactive for the antibody to hepatitis C virus. The recall was added to the FDA's Enforcement Report on August 13, 2026, and involved product distributed in Minnesota.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- New York Blood Center Inc
- Hazard
- Contamination
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99474
- Recall number
- B-0185-2026
All recalls from New York Blood Center Inc
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
